The management of Irvine-Gass Syndrome in a patient using Inhaler Steroid
Open Access
- 7 February 2018
- journal article
- Published by Heighten Science Publications Corporation in International Journal of Clinical and Experimental Ophthalmology
- Vol. 2 (1), 001-005
- https://doi.org/10.29328/journal.ijceo.1001011
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Dexamethasone Intravitreal Implant for Treatment of Patients With Recalcitrant Macular Edema Resulting From Irvine-Gass SyndromeInvestigative Ophthalmology & Visual Science, 2013
- Intravitreal Ranibizumab for the Treatment of Cystoid Macular Edema in Irvine-Gass SyndromeJournal of Ocular Pharmacology and Therapeutics, 2012
- Ketorolac therapy for the prevention of acute pseudophakic cystoid macular edema: a systematic reviewEye, 2011
- Prevalence of optical coherence tomography‐diagnosed postoperative cystoid macular oedema in patients following uncomplicated phaco‐emulsification cataract surgeryClinical & Experimental Ophthalmology, 2011
- Pseudophakic Cystoid Macular EdemaInternational Ophthalmology Clinics, 2010
- Dexamethasone Posterior-Segment Drug Delivery System in the Treatment of Macular Edema Resulting from Uveitis or Irvine-Gass SyndromeAmerican Journal of Ophthalmology, 2009
- SHORT-TERM SAFETY AND EFFICACY OF INTRAVITREAL BEVACIZUMAB FOR PSEUDOPHAKIC CYSTOID MACULAR EDEMARetina, 2009
- Efficacy of intravitreal bevacizumab in treating postoperative pseudophakic cystoid macular edemaJournal of Cataract & Refractive Surgery, 2008
- Clinical pseudophakic cystoid macular edemaJournal of Cataract & Refractive Surgery, 2007
- Lens Opacities Classification System II (LOCS II)American Journal of Ophthalmology, 1989